SI2340506T1 - Biomarkerji za pljučni rak in njihove uporabe - Google Patents
Biomarkerji za pljučni rak in njihove uporabeInfo
- Publication number
- SI2340506T1 SI2340506T1 SI200931363T SI200931363T SI2340506T1 SI 2340506 T1 SI2340506 T1 SI 2340506T1 SI 200931363 T SI200931363 T SI 200931363T SI 200931363 T SI200931363 T SI 200931363T SI 2340506 T1 SI2340506 T1 SI 2340506T1
- Authority
- SI
- Slovenia
- Prior art keywords
- lung cancer
- cancer biomarkers
- biomarkers
- lung
- cancer
- Prior art date
Links
- 206010058467 Lung neoplasm malignant Diseases 0.000 title 1
- 201000005202 lung cancer Diseases 0.000 title 1
- 208000020816 lung neoplasm Diseases 0.000 title 1
- 239000000107 tumor biomarker Substances 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
- G06F17/10—Complex mathematical operations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Data Mining & Analysis (AREA)
- Theoretical Computer Science (AREA)
- Mathematical Physics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Pure & Applied Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mathematical Analysis (AREA)
- Mathematical Optimization (AREA)
- Plant Pathology (AREA)
- Software Systems (AREA)
- Databases & Information Systems (AREA)
- Computational Mathematics (AREA)
- Biophysics (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9559308P | 2008-09-09 | 2008-09-09 | |
| US15283709P | 2009-02-16 | 2009-02-16 | |
| PCT/US2009/056399 WO2010030697A1 (en) | 2008-09-09 | 2009-09-09 | Lung cancer biomarkers and uses thereof |
| EP09813557.7A EP2340506B1 (en) | 2008-09-09 | 2009-09-09 | Lung cancer biomarkers and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2340506T1 true SI2340506T1 (sl) | 2016-02-29 |
Family
ID=42005456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200931363T SI2340506T1 (sl) | 2008-09-09 | 2009-09-09 | Biomarkerji za pljučni rak in njihove uporabe |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP2340506B1 (sl) |
| JP (1) | JP5701212B2 (sl) |
| KR (1) | KR101658347B1 (sl) |
| CN (2) | CN104198709A (sl) |
| AU (2) | AU2009291811B2 (sl) |
| CA (3) | CA3152591C (sl) |
| DK (1) | DK2340506T3 (sl) |
| ES (1) | ES2559758T3 (sl) |
| GB (1) | GB2478441B (sl) |
| HK (2) | HK1153834A1 (sl) |
| HR (1) | HRP20160127T1 (sl) |
| MX (1) | MX2011002322A (sl) |
| SI (1) | SI2340506T1 (sl) |
| WO (1) | WO2010030697A1 (sl) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10359425B2 (en) | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| AU2010223911A1 (en) | 2009-03-12 | 2011-10-06 | Cancer Prevention And Cure, Ltd. | Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy |
| JP5905003B2 (ja) * | 2010-07-09 | 2016-04-20 | ソマロジック・インコーポレーテッド | 肺癌バイオマーカーとその使用 |
| BR112013003391B8 (pt) | 2010-08-13 | 2022-10-25 | Somalogic Inc | Método para diagnosticar câncer pancreático em um indivíduo |
| ES2746929T3 (es) * | 2011-04-07 | 2020-03-09 | Scripps Research Inst | Cribado de alto rendimiento para compuestos que modulan los niveles de macromoléculas celulares |
| EP3249408A1 (en) | 2011-04-29 | 2017-11-29 | Cancer Prevention And Cure, Ltd. | Methods of identification and diagnosis of lung diseases using classification systems and kits thereof |
| JP5986638B2 (ja) * | 2011-10-24 | 2016-09-06 | ソマロジック・インコーポレーテッド | 肺癌バイオマーカーおよびその使用 |
| US11913957B2 (en) | 2011-12-21 | 2024-02-27 | Biodesix, Inc. | Compositions, methods and kits for diagnosis of lung cancer |
| AU2012358246B2 (en) | 2011-12-21 | 2018-01-25 | Integrated Diagnostics, Inc. | Methods for diagnosis of lung cancer |
| US9304137B2 (en) | 2011-12-21 | 2016-04-05 | Integrated Diagnostics, Inc. | Compositions, methods and kits for diagnosis of lung cancer |
| CN104115150B (zh) * | 2012-02-17 | 2018-05-04 | 皇家飞利浦有限公司 | 急性肺损伤(ali)/急性呼吸窘迫整合征(ards)评估和监测 |
| WO2014074682A1 (en) | 2012-11-07 | 2014-05-15 | Somalogic, Inc. | Chronic obstructive pulmonary disease (copd) biomarkers and uses thereof |
| US11031105B2 (en) | 2013-11-07 | 2021-06-08 | Medial Research Ltd. | Methods and systems of evaluating a risk of lung cancer |
| CN108026584B (zh) * | 2015-09-11 | 2021-12-10 | 适体科学株式会社 | 非小细胞肺癌诊断用蛋白质生物标志物组及利用其的非小细胞肺癌诊断方法 |
| FR3050269B1 (fr) * | 2016-04-15 | 2018-05-11 | Ecole Superieure De Physique Et De Chimie Industrielles De La Ville De Paris (Espci) | Procede de selection et de recuperation de produits et systeme associe |
| CN105823665A (zh) * | 2016-05-13 | 2016-08-03 | 北京九州柏林生物科技有限公司 | 生物组织样本制备套液 |
| CA3026809A1 (en) | 2016-06-21 | 2017-12-28 | The Wistar Institute Of Anatomy And Biology | Compositions and methods for diagnosing lung cancers using gene expression profiles |
| JP6280997B1 (ja) * | 2016-10-31 | 2018-02-14 | 株式会社Ｐｒｅｆｅｒｒｅｄ Ｎｅｔｗｏｒｋｓ | 疾患の罹患判定装置、疾患の罹患判定方法、疾患の特徴抽出装置及び疾患の特徴抽出方法 |
| WO2018187496A2 (en) | 2017-04-04 | 2018-10-11 | Lung Cancer Proteomics, Llc | Plasma based protein profiling for early stage lung cancer prognosis |
| MY202410A (en) | 2017-09-01 | 2024-04-27 | Venn Biosciences Corp | Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring |
| CA3083097A1 (en) | 2017-11-22 | 2019-05-31 | Gritstone Oncology, Inc. | Reducing junction epitope presentation for neoantigens |
| CA3085464A1 (en) | 2017-12-19 | 2019-06-27 | The Wistar Institute Of Anatomy And Biology | Compositions and methods for diagnosing lung cancers using gene expression profiles |
| WO2019246289A1 (en) * | 2018-06-22 | 2019-12-26 | Somalogic, Inc. | Improved proteomic multiplex assays |
| EP3987292A4 (en) * | 2019-06-21 | 2023-10-11 | National University of Singapore | Methods for determining the likelihood of lung cancer |
| CN110579611B (zh) * | 2019-09-18 | 2023-01-31 | 郑州大学 | 一种用于肺癌早期筛查和诊断的联合检测血清标志物、试剂盒及检测方法 |
| CN111047609B (zh) * | 2020-03-13 | 2020-07-24 | 北京深睿博联科技有限责任公司 | 肺炎病灶分割方法和装置 |
| WO2022073502A1 (zh) * | 2020-10-10 | 2022-04-14 | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 生物标志物在制备肺癌检测试剂中的用途和方法 |
| CN112557514B (zh) * | 2020-12-22 | 2021-09-21 | 中国海洋大学 | 手持式海底沉积物样品剖面声学全自动测量装置 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596503B1 (en) * | 2000-08-18 | 2003-07-22 | East Carolina University | Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof |
| US20030190602A1 (en) * | 2001-03-12 | 2003-10-09 | Monogen, Inc. | Cell-based detection and differentiation of disease states |
| CN1554025A (zh) * | 2001-03-12 | 2004-12-08 | Īŵ���ɷ�����˾ | 患病状态的细胞为基础的检测和鉴别 |
| CA2444691A1 (en) * | 2001-04-18 | 2002-10-31 | Protein Design Labs, Inc. | Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| WO2004061410A2 (en) * | 2002-12-18 | 2004-07-22 | Ciphergen Biosystems, Inc. | Serum biomarkers in lung cancer |
| CN1225477C (zh) * | 2003-03-28 | 2005-11-02 | 上海市疾病预防控制中心 | 肺癌早期血清特异蛋白及其应用 |
| CN1455257A (zh) * | 2003-05-23 | 2003-11-12 | 北京师范大学 | 一种利用表面修饰蛋白芯片进行肺癌诊断方法 |
| WO2005090603A2 (en) * | 2004-03-23 | 2005-09-29 | Oncotherapy Science, Inc. | Method for diagnosing non-small cell lung cancer |
| JP2005304497A (ja) * | 2004-03-25 | 2005-11-04 | Joji Inasawa | 特定の癌関連遺伝子を用いる癌の検出方法及び癌の抑制方法 |
| US7456027B2 (en) * | 2004-04-15 | 2008-11-25 | University Of Florida Research Foundation, Inc. | Proteolytic biomarkers for traumatic injury to the nervous system |
| BRPI0510266A (pt) * | 2004-04-26 | 2007-10-30 | Childrens Medical Center | métodos para a detecção de uma doença ou distúrbio angiogênico em um indivìduo, para a detecção de cáncer em um indivìduo, para o tratamento de um indivìduo afetado com uma doença ou distúrbio angiogênico, para a determinação da probabilidade de eficácia de uma terapia anti-angiogênica, para a determinação da eficácia de uma terapia de teste na modulação dos nìveis de reguladores angiogênicos de plaqueta, para a criação de um registro ou perfil de plaqueta para uma doença ou distúrbio angiogênico e para a monitoração da eficácia de uma terapia em um indivìduo com uma doença ou distúrbio angiogênico |
| KR20070043868A (ko) * | 2004-08-02 | 2007-04-25 | 칠드런'즈 메디컬 센터 코포레이션 | 암에 대한 혈소판 바이오마커 |
| CN1873417A (zh) * | 2005-06-02 | 2006-12-06 | 中国医学科学院肿瘤医院肿瘤研究所 | 一种用于诊断肺癌的蛋白质芯片 |
| CA2821426A1 (en) * | 2005-12-22 | 2007-07-05 | Abbott Laboratories | Methods and marker combinations for screening for predisposition to lung cancer |
| US7908091B2 (en) * | 2006-03-17 | 2011-03-15 | Prometheus Laboratories Inc. | Methods of predicting and monitoring tyrosine kinase inhibitor therapy |
| US20080195327A1 (en) * | 2006-10-17 | 2008-08-14 | Synergenz Bioscience Limited | Methods of Analysis of Polymorphisms and Uses Thereof |
| WO2008097908A2 (en) * | 2007-02-05 | 2008-08-14 | Dana-Farber Cancer Institute, Inc. | Methods of diagnosing and prognosing lung cancer |
| KR100846354B1 (ko) * | 2007-03-21 | 2008-07-15 | (주) 프로탄바이오 | 혈청 당단백질부터 분리한 폐암 진단용 마커 |
| CA2684945A1 (en) * | 2007-05-18 | 2008-11-27 | University Of Southern California | Germline polymorphisms in the angiogenic pathway predict tumor recurrence in cancer therapy |
| US7888051B2 (en) * | 2007-09-11 | 2011-02-15 | Cancer Prevention And Cure, Ltd. | Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues |
| WO2010003772A1 (en) * | 2008-06-16 | 2010-01-14 | Siemens Medical Solutions Diagnostics Gmbh | Method for predicting adverse response to erythropoietin in breast cancer treatment |
| US10359425B2 (en) * | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| AU2011215789A1 (en) * | 2010-02-10 | 2012-08-30 | The Regents Of The University Of California | Salivary biomarkers for lung cancer detection |
-
2009
- 2009-09-09 CA CA3152591A patent/CA3152591C/en active Active
- 2009-09-09 AU AU2009291811A patent/AU2009291811B2/en active Active
- 2009-09-09 ES ES09813557.7T patent/ES2559758T3/es active Active
- 2009-09-09 JP JP2011526308A patent/JP5701212B2/ja active Active
- 2009-09-09 EP EP09813557.7A patent/EP2340506B1/en active Active
- 2009-09-09 GB GB1106053.0A patent/GB2478441B/en active Active
- 2009-09-09 WO PCT/US2009/056399 patent/WO2010030697A1/en active Application Filing
- 2009-09-09 CA CA3011730A patent/CA3011730C/en active Active
- 2009-09-09 DK DK09813557.7T patent/DK2340506T3/en active
- 2009-09-09 CN CN201410477840.7A patent/CN104198709A/zh active Pending
- 2009-09-09 CA CA2734535A patent/CA2734535C/en active Active
- 2009-09-09 KR KR1020117005305A patent/KR101658347B1/ko active Active
- 2009-09-09 SI SI200931363T patent/SI2340506T1/sl unknown
- 2009-09-09 MX MX2011002322A patent/MX2011002322A/es active IP Right Grant
- 2009-09-09 CN CN200980144620.XA patent/CN102209968B/zh active Active
-
2011
- 2011-07-29 HK HK11107896.7A patent/HK1153834A1/xx unknown
-
2015
- 2015-05-18 HK HK15104677.5A patent/HK1204062A1/xx unknown
- 2015-10-29 AU AU2015249113A patent/AU2015249113B2/en active Active
-
2016
- 2016-02-04 HR HRP20160127TT patent/HRP20160127T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN102209968B (zh) | 2016-05-04 |
| MX2011002322A (es) | 2011-05-10 |
| GB2478441B (en) | 2013-03-27 |
| AU2015249113A1 (en) | 2015-11-12 |
| JP2012502281A (ja) | 2012-01-26 |
| KR101658347B1 (ko) | 2016-09-21 |
| KR20110063753A (ko) | 2011-06-14 |
| CN102209968A (zh) | 2011-10-05 |
| CA3011730A1 (en) | 2010-03-18 |
| AU2009291811A1 (en) | 2010-03-18 |
| CA3152591C (en) | 2023-08-29 |
| CA2734535C (en) | 2018-08-28 |
| EP2340506A1 (en) | 2011-07-06 |
| HK1153834A1 (en) | 2012-04-05 |
| HK1204062A1 (en) | 2015-11-06 |
| WO2010030697A1 (en) | 2010-03-18 |
| CA3152591A1 (en) | 2010-03-18 |
| JP5701212B2 (ja) | 2015-04-15 |
| GB2478441A (en) | 2011-09-07 |
| CN104198709A (zh) | 2014-12-10 |
| AU2015249113B2 (en) | 2017-09-07 |
| AU2009291811B2 (en) | 2015-10-29 |
| CA2734535A1 (en) | 2010-03-18 |
| ES2559758T3 (es) | 2016-02-15 |
| GB201106053D0 (en) | 2011-05-25 |
| CA3011730C (en) | 2022-05-17 |
| HRP20160127T1 (hr) | 2016-03-11 |
| DK2340506T3 (en) | 2016-02-08 |
| EP2340506A4 (en) | 2012-02-15 |
| EP2340506B1 (en) | 2015-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2478441B (en) | Lung cancer biomarkers and uses thereof | |
| IL269454B (en) | Qualitative losses and their uses | |
| IL223295A0 (en) | Lung cancer biomarkers and uses thereof | |
| GB0719792D0 (en) | Cancer biomarkers | |
| IL252163A0 (en) | Lung cancer biomarkers and their uses | |
| IL202727A0 (en) | Covalent diabodies and uses thereof | |
| SG2014007454A (en) | Pancreatic cancer biomarkers and uses thereof | |
| EP2382331A4 (en) | KREBSBIOMARKER | |
| GB0616230D0 (en) | Biomarkers and uses thereof | |
| GB0818660D0 (en) | Biomarkers | |
| EP2350917A4 (en) | BIOMARKERS OF OVARIAN CANCER AND USES THEREOF | |
| GB0807214D0 (en) | Biomarkers | |
| GB0821912D0 (en) | Biomarkers | |
| GB0818658D0 (en) | Biomarkers | |
| GB0720334D0 (en) | Cancer biomarker | |
| AU2009900954A0 (en) | Cancer Biomarkers and Uses Therefor | |
| GB0809105D0 (en) | Biomarkers | |
| GB0805084D0 (en) | Biomarkers | |
| GB0805081D0 (en) | Biomarkers |